Add
Compare:
Overview:
There are 11 differences and 10 similarities between Adderall, Metadate ER
| Basic Information |
| Generic Name |
| Amphetamine And Dextroamphetamine |
Methylphenidate |
| Class |
| Cns Stimulants |
Cns Stimulants |
| Prescription Generic Available |
| Yes |
Yes |
| Pregnancy cat. |
| C(us) |
C(us) |
| Approved Age |
| 3 And Older |
6 And Older |
| Legal Status |
| Schedule I (ca) Schedule Ii (us) |
Schedule Ii (us) |
| WADA Category |
| S6 - Stimulants |
S6 - Stimulants |
| Dependence Liability |
| High |
Moderate |
| Excretion |
| Urinary |
Urinary |
| Possible Side Effects |
| Some Loss Of Appetite, Weight Loss, Sleep Problems, Irritability, Tics. |
Some Loss Of Appetite, Weight Loss, Sleep Problems, Irritability, Tics. |
|
| Dosage, Usage and Forms |
| Routes (of administration) |
| (medical) Oral, Insufflated, Intravenous |
Oral |
| Dosage |
| 5–30 Mg Bid Or 5–60 Mg Q
Am |
10 Mg Q Am–30 Bid (max
60mg/day) |
|
Maximum daily dose |
| 60 mg |
60 mg |
| Duration |
| Intermediate-acting |
Intermediate-acting |
| Duration - time |
| 4-8 H |
6-8 H |
| Chemical Data |
| Molecular mass (g/mol) |
| 135.21 G/mol |
269.77 G/mol |
| Half Life |
| 10 Hours |
3.4 Hours |
| Formula |
| C9h13n |
C14h19no2•hcl |
| Bioavailability |
| Nasal 75%; Rectal 95-99%; Intravenous 100% |
30 % |
| Protein binding |
| 15-40% |
15 % |
| Metabolism |
| Hepatic |
Hepatic |